tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech advances REO 033 colorectal cancer program
Company AnnouncementsOncolytics Biotech advances REO 033 colorectal cancer program
6d ago
8K
ONCY
Oncolytics provides clinical, regulatory update on REO 033
PremiumThe Fly
Oncolytics provides clinical, regulatory update on REO 033
6d ago
ONCY
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
PremiumCompany Announcements
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
1M ago
8K
ONCY
Oncolytics secures new patent for pelareorep manufacturing
PremiumThe Fly
Oncolytics secures new patent for pelareorep manufacturing
1M ago
ONCY
Oncolytics promotes John McAdory to COO
PremiumThe Fly
Oncolytics promotes John McAdory to COO
2M ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
PremiumCompany AnnouncementsOncolytics Biotech Strengthens Leadership with New COO, Director
2M ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
Premium
Company Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
2M ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
Premium
The Fly
Oncolytics announces initial data from pelareorep combination study
2M ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
PremiumThe Fly
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
2M ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
PremiumCompany Announcements
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
2M ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
PremiumRatings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
2M ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
PremiumCompany Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
3M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
PremiumThe FlyOncolytics says in alignment with FDA following pelareorep Type C meeting
3M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
Premium
Company Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
3M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
Premium
Ratings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
3M ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
PremiumThe Fly
Oncolytics price target lowered to $5 from $7 at Lake Street
3M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
PremiumCompany Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
3M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
PremiumCompany Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
3M ago
8K
ONCY
Oncolytics schedules FDA meeting for pelareorep registrational path
PremiumThe Fly
Oncolytics schedules FDA meeting for pelareorep registrational path
3M ago
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
PremiumCompany AnnouncementsOncolytics Biotech Completes Domestication to Nevada with New Governance
4M ago
8K
ONCY
Oncolytics completes domicile change to the U.S.
Premium
The Fly
Oncolytics completes domicile change to the U.S.
4M ago
ONCY
Oncolytics files $250M mixed securities shelf
Premium
The Fly
Oncolytics files $250M mixed securities shelf
4M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >